Long-term safety and efficacy of elagolix treatment in women with endometriosis-associated pain: primary results from two phase 3 extension studies

Eric S. Surrey, Hugh S. Taylor, L.C. Giudice, S. S. Singh, Maurício Simões Abrão, Bruce A. Lessey, W. Rachel Duan, Paul M. Peloso, Brittany Schwefel, Kristof Chwalisż
In: Fertility and Sterility · 2017 · vol. 108(3) , pp. e95–e96 · doi:10.1016/j.fertnstert.2017.07.293 · W2751463235
article OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Two Phase 3 extension studies evaluated the long-term safety and efficacy of elagolix for women with endometriosis-associated pain, reporting primary outcomes of this extended treatment period.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK